Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data

Christine L Baker,1 Kelly H Zou,1 Jun Su21Pfizer Inc., New York, NY, USA; 2Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USABackground: Treatment of stable chronic obstructive pulmonary disease (COPD) with long-acting bronchodilator (LABD) medications is recommended by the 2014 Global...

Full description

Bibliographic Details
Main Authors: Baker CL, Zou KH, Su J
Format: Article
Language:English
Published: Dove Medical Press 2014-05-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/long-acting-bronchodilator-use-after-hospitalization-for-copd-an-obser-a16627

Similar Items